Newswise — ORLANDO, Fla. — Cancer is at its most treatable when caught early, so scientists are increasing their focus on innovative diagnostic methods that, hopefully, will lead to higher cure rates.
At the AACR 102nd Annual Meeting 2011, held April 2-6, David Sidransky, M.D., director, Head and Neck Cancer Research at Johns Hopkins and professor of otolaryngology-head and neck surgery, oncology, pathology, cellular and molecular medicine, and urology, will host a press conference on some of the new arenas being explored.
The press conference will take place on Monday, April 4 at 8:30 a.m. ET in room W313 of the Orange County Convention Center. It will feature the following research:• Serum Test Could Identify Lung Cancer in People Who Never Smoked• Protein Test Detects Early-stage, Asbestos-related Pulmonary Cancer• Breast Milk May Provide a Personalized Screen of Breast Cancer Risk
Reporters who cannot attend in person can participate using the following information:• U.S. & Canada: (888) 647-7462• International: (201) 604-0169• Access Code: 244090
Press registration for the AACR 102nd Annual Meeting 2011 is free to qualified journalists and public information officers: http://www.aacr.org/PressRegistration
Follow the AACR on Twitter: @AACR #AACRFollow the AACR on Facebook: http://www.facebook.com/aacr.org
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.